(Q38550285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

title

Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Siddharth Singh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Alina M Allen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

M Hassan Murad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Rohit Loomba

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

English

0 references

publication date

1 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

1417-1432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

The global NAFLD epidemic

19 February 2020

cites work

1 reference

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

21 January 2018

1 reference

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

21 January 2018

1 reference

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

21 January 2018

1 reference

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

State of the art: treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

21 January 2018

1 reference

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

How to use an article reporting a multiple treatment comparison meta-analysis.

21 January 2018

1 reference

Combination of direct and indirect evidence in mixed treatment comparisons

21 January 2018

1 reference

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

21 January 2018

1 reference

The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement.

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials

21 January 2018

1 reference

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

21 January 2018

1 reference

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

21 January 2018

1 reference

Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver

21 January 2018

1 reference

The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial.

21 January 2018

1 reference

Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

21 January 2018

1 reference

Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.

21 January 2018

1 reference

Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial

21 January 2018

1 reference

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet

21 January 2018

1 reference

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism

21 January 2018

1 reference

Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis

21 January 2018

1 reference

Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop

21 January 2018

1 reference

FDA eases restrictions on the glucose-lowering drug rosiglitazone.

21 January 2018

1 reference

Conceptual and Technical Challenges in Network Meta-analysis

21 January 2018

1 reference

Randomized Trial of Pentoxifylline and Vitamin E vs Standard Follow-up After Breast Irradiation to Prevent Breast Fibrosis, Evaluated by Tissue Compliance Meter

21 January 2018

1 reference

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

21 January 2018

1 reference

7 January 2021

Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial

1 reference

7 January 2021

Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis

1 reference

7 January 2021

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis

1 reference

7 January 2021

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

1 reference

7 January 2021

Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.27999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26189925%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference